About Us

Servier Australia

Servier Australia is the local subsidiary of Servier, a leading French research-based pharmaceutical entity, specialising in ethical pharmaceuticals. Employing over 150 people in Australia, Servier Headquarters are in Hawthorn, Melbourne. In 2013 Servier Australia had an annual turnover of over $107 million AUD.

Servier Laboratories Limited comprises two principal divisions:

  1. Clinical Research
    The management of phase l, ll, lll and lV clinical trials in collaboration with research-based hospitals and general practices throughout Australia.
  2. Sales and Marketing
    Sales and Marketing deliver Servier's portfolio of ethical pharmaceutical products to healthcare professionals

In addition to a team of representatives throughout Australia, to support the operational activities of the above divisions, there is naturally a complete range of professional support functions that include the following: Training, Marketing, Regulatory Affairs, Human Resources, Finance, Information Services, Strategic Coordination, External and Government Relations and Medical Affairs.

Servier Australia offers a range of products in a number of medical areas: cardiovascular disease, especially hypertension and cardiac disease, diabetes, osteoporosis and more recently depression.

Servier Internationally

In the short space of 50 years, Servier has developed in stature from a family-owned, provincial pharmacy employing nine people to a multi-national operation with over 20,000 employees worldwide, including nearly 3,000 in R&D. Despite its significant growth in recent years, the Company is still privately owned and is passionately and permanently committed to remaining independent.

Currently the second largest French pharmaceutical company worldwide, it is also the largest privately owned and the second largest exporter of pharmaceutical products.

Established in 140 countries, Servier has achieved consistently high growth especially throughout the last decade. The reason for this success is three-fold: firstly, one of the world's highest ratios of investment in research and development; secondly, an enviable reputation for product innovation; thirdly, the motivation, commitment and professionalism of the Company's personnel are second to none.